Optimum Investment Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $31.1K | Buy |
310
+10
| +3% | +$901 | 0.01% | 400 |
|
|
2025
Q2 | $24.9K | Hold |
300
| – | – | 0.01% | 420 |
|
|
2025
Q1 | $24.3K | Sell |
300
-400
| -57% | -$35.8K | 0.01% | 419 |
|
|
2024
Q4 | $63K | Hold |
700
| – | – | 0.03% | 313 |
|
|
2024
Q3 | $69.2K | Hold |
700
| – | – | 0.03% | 316 |
|
|
2024
Q2 | $64.9K | Hold |
700
| – | – | 0.03% | 329 |
|
|
2024
Q1 | $66.4K | Hold |
700
| – | – | 0.03% | 327 |
|
|
2023
Q4 | $62.5K | Hold |
700
| – | – | 0.03% | 325 |
|
|
2023
Q3 | $51.1K | Hold |
700
| – | – | 0.03% | 360 |
|
|
2023
Q2 | $58.2K | Hold |
700
| – | – | 0.03% | 357 |
|
|
2023
Q1 | $53.3K | Sell |
700
-150
| -18% | -$12.4K | 0.03% | 361 |
|
|
2022
Q4 | $70.5K | Buy |
850
+150
| +21% | +$12.1K | 0.04% | 331 |
|
|
2022
Q3 | $56K | Hold |
700
| – | – | 0.03% | 363 |
|
|
2022
Q2 | $52K | Hold |
700
| – | – | 0.03% | 393 |
|
|
2022
Q1 | $63K | Hold |
700
| – | – | 0.03% | 395 |
|
|
2021
Q4 | $78K | Hold |
700
| – | – | 0.03% | 384 |
|
|
2021
Q3 | $88K | Sell |
700
-400
| -36% | -$51.5K | 0.04% | 351 |
|
|
2021
Q2 | $149K | Hold |
1,100
| – | – | 0.05% | 319 |
|
|
2021
Q1 | $149K | Hold |
1,100
| – | – | 0.04% | 315 |
|
|
2020
Q4 | $155K | Hold |
1,100
| – | – | 0.05% | 290 |
|
|
2020
Q3 | $123K | Hold |
1,100
| – | – | 0.04% | 301 |
|
|
2020
Q2 | $123K | Hold |
1,100
| – | – | 0.04% | 292 |
|
|
2020
Q1 | $85K | Buy |
1,100
+300
| +38% | +$26.6K | 0.03% | 337 |
|
|
2019
Q4 | $76K | Sell |
800
-80
| -9% | -$6.92K | 0.02% | 439 |
|
|
2019
Q3 | $67K | Buy |
880
+80
| +10% | +$6.65K | 0.02% | 456 |
|
|
2019
Q2 | $70K | Hold |
800
| – | – | 0.02% | 441 |
|
|
2019
Q1 | $72K | Sell |
800
-100
| -11% | -$8.51K | 0.02% | 439 |
|
|
2018
Q4 | $65K | Hold |
900
| – | – | 0.02% | 420 |
|
|
2018
Q3 | $86K | Hold |
900
| – | – | 0.02% | 428 |
|
|
2018
Q2 | $86K | Hold |
900
| – | – | 0.02% | 421 |
|
|
2018
Q1 | $79K | Buy |
+900
| New | +$82.2K | 0.02% | 446 |
|
|
2015
Q1 | $23K | Hold |
309
| – | – | 0.01% | 665 |
|
|
2014
Q4 | $19K | Hold |
309
| – | – | 0.01% | 737 |
|
|
2014
Q3 | $18K | Sell |
309
-600
| -66% | -$30.6K | 0.01% | 669 |
|
|
2014
Q2 | $47K | Buy |
909
+309
| +52% | +$13.9K | 0.02% | 494 |
|
|
2014
Q1 | $28K | Buy |
+600
| New | +$30.7K | 0.01% | 461 |
|
Other funds holding XBI
Optimum Investment Advisors's XBI Position: Q3 2025 in Review
Optimum Investment Advisors increased its State Street SPDR S&P Biotech ETF (XBI) stake by 3.3% in Q3 2025, buying an estimated $901 and bringing the position to 310 shares worth $31.1K. The position accounts for 0.01% of the portfolio, ranked #400.
Optimum Investment Advisors first reported a position in XBI in Q1 2014 and has held it in 36 quarters since. The position peaked at $155K in Q4 2020. 656 funds tracked by Wall St. Rank hold XBI as of Q3 2025.
- Optimum Investment Advisors held 310 shares of State Street SPDR S&P Biotech ETF worth $31.1K as of Q3 2025.
- Optimum Investment Advisors bought 10 State Street SPDR S&P Biotech ETF shares in Q3 2025, an estimated $901.
- State Street SPDR S&P Biotech ETF made up 0.01% of Optimum Investment Advisors's portfolio in Q3 2025, its #400 holding.
- Optimum Investment Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q1 2014 and has held it in 36 quarters since.
- Optimum Investment Advisors's State Street SPDR S&P Biotech ETF position peaked at $155K in Q4 2020.
- 656 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2025.
Based on Optimum Investment Advisors's 13F filing for Q3 2025, filed 21 Oct 2025.